ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) is moving a bit lower this morning after the news. After reaching a new high of $5.95% in early-February, the stock has lost almost half of its value as the biotech sector came in under pressure after last year’s rally.
Ziopharm Oncology to Participate in Upcoming Conferences
- ZIOP announced that Company management will participate in two upcoming investor conferences:
- The Jefferies Virtual Healthcare Conference, taking place June 1-4, 2021: Interim Chief Executive Officer Heidi Hagen and Chief Medical Officer Raffaele Baffa will participate in a fireside chat on June 4 at 1pm ET.
- The Virtual Raymond James Human Health Innovations Conference, taking place June 21-23, 2021: Interim Chief Executive Officer Heidi Hagen will participate in a fireside chat on June 22 at 2:40pm ET.
As of 11:19, ZIOP stock is trading lower by 2.33% to $2.98. The stock has witnessed volume of 2952K on shares, compared to its average volume of 1.92 million.
Recent Stock Performance
|+/- EMA(20)||3.16 (-5.38%)|
|+/- SMA(50)||3.39 (-11.80%)|
|+/- SMA(200)||3.24 (-7.72%)|